Oncogenic BRAF and p53 Interplay in Melanoma Cells and the Effects of the HDAC Inhibitor ITF2357 (Givinostat)
Adriana Celesia(University of Palermo), Sonia Emanuele(University of Palermo)
Cited by 13
Related Papers
Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
|Biomedicines|2022|46
The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis
|Biomedicines|2022|11
The Antitumor Potential of Sicilian Grape Pomace Extract: A Balance between ROS-Mediated Autophagy and Apoptosis
|Biomolecules|2024|5
Targeting lipogenesis promotes the synergistic effect of the selective HDAC6 inhibitor ITF3756 with bortezomib in colon cancer cells
|Frontiers in Pharmacology|2025|0